Motoki Fujimaki

Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease

Shinji Saiki, Taku Hatano, Motoki Fujimaki et al. · Scientific Reports · 2017 · 140 citations · Full text

A metabolic profile of polyamines in parkinson disease: A promising biomarker

Shinji Saiki, Yukiko Sasazawa, Motoki Fujimaki et al. · Annals of Neurology · 2019 · 120 citations · Full text

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease

Motoki Fujimaki, Shinji Saiki, Yuanzhe Li et al. · Neurology · 2018 · 103 citations · Full text

Iron Supply via NCOA4-Mediated Ferritin Degradation Maintains Mitochondrial Functions

Motoki Fujimaki, Norihiko Furuya, Shinji Saiki et al. · Molecular and Cellular Biology · 2019 · 79 citations · Full text

Mitophagy, Biochemistry, Mitochondrial Function +15

Metabolomics‐based identification of metabolic alterations in PARK2

Ayami Okuzumi, Taku Hatano, Shin‐Ichi Ueno et al. · Annals of Clinical and Translational Neurology · 2019 · 60 citations · Full text